Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of pulsatilla saponin B4 in preparation of medicine for treating or preventing SARS-CoV-2

A technology of Pulsatilla saponins, sars-cov-2, applied in the field of medicine

Pending Publication Date: 2022-04-22
广西馨海药业科技有限公司
View PDF2 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no report on the effect of Pulsatilla saponin B4 on the prevention and treatment of COVID-19 caused by SARS-CoV-2 infection

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of pulsatilla saponin B4 in preparation of medicine for treating or preventing SARS-CoV-2
  • Application of pulsatilla saponin B4 in preparation of medicine for treating or preventing SARS-CoV-2
  • Application of pulsatilla saponin B4 in preparation of medicine for treating or preventing SARS-CoV-2

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] The present invention will be further described in detail below in conjunction with the accompanying drawings, so that those skilled in the art can implement it with reference to the description.

[0022] It should be understood that terms such as "having", "comprising" and "including" used herein do not exclude the presence or addition of one or more other elements or combinations thereof.

[0023] It should be noted that the experimental methods described in the following embodiments, unless otherwise specified, are conventional methods, and the reagents and materials, unless otherwise specified, can be obtained from commercial sources.

[0024] Pulsatilla saponin B4 is used in the preparation of medicines for the treatment or prevention of COVID-19 caused by SARS-CoV-2 infection.

[0025] The medicine contains therapeutically effective dose of Pulsatilla saponin B4 and a pharmaceutically acceptable carrier. or,

[0026] The medicine contains therapeutically effecti...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of pulsatilla saponin B4 in preparation of a medicine for treating or preventing COVID-19 (COVID-19) caused by SARS-CoV-2 infection. B4 has an autoimmune regulation effect, on one hand, immune cells kill pathogenic microorganisms, and on the other hand, inflammation caused by the pathogenic microorganisms is reduced, so that the lung protection effect is achieved, and a certain protection effect is achieved on ACE2 mice caused by novel coronavirus SARS-CoV-2 infection.

Description

technical field [0001] The invention relates to the technical field of medicine. More specifically, the present invention relates to the use of Pulsatilla saponin B4 in the preparation of medicines for treating or preventing SARS-CoV-2. Background technique [0002] The pneumonia caused by the new coronavirus is mainly manifested by fever, fatigue, and dry cough, and a small number of patients are accompanied by symptoms such as nasal congestion, runny nose, and diarrhea. Severe cases will have dyspnea, and severe cases will rapidly develop symptoms of lung injury such as acute respiratory distress syndrome and septic shock. Because there is no specific drug treatment for COVID-19. Therefore, it is of great significance to strengthen research on the treatment of COVID-19 and explore ways to treat COVID-19. [0003] At present, clinically used drugs for the treatment of pneumonia and lung injury, such as antibiotics, hormones (dexamethasone), antiviral drugs (ribavirin), e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/704A61P31/14
CPCA61K31/704A61P31/14
Inventor 杨世林许琼明高红伟刘艳丽苑仁祎坤
Owner 广西馨海药业科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com